0:00
/
0:00

Paid episode

The full episode is only available to paid subscribers of Antifragile Thinking

3Q FY25 analysis and next steps: Advanced Enzymes, Windlas, Kopran, Neuland, Eureka, SeQuent, Aarti Pharma, Shivalik

Rule 1: Positive forward rate of change

Rule 2: Business bottom (Point A)

Rule 1 is more important than Rule 2.

Forget retail; even the institutions and HNIs made the mistake of taking their eyes off R…

Listen to this episode with a 7-day free trial

Subscribe to Antifragile Thinking to listen to this post and get 7 days of free access to the full post archives.